Literature DB >> 12383901

A prospective review of the decline of excisional breast biopsy.

Joseph P Crowe1, Alice Rim, Rebecca Patrick, Lisa Rybicki, Sharon Grundfest, Julian Kim, Katherine Lee, Lawrence Levy.   

Abstract

BACKGROUND: Although excisional breast biopsy has long been considered the standard for breast cancer diagnosis, core biopsies are now used more frequently. Whether core biopsy can eventually replace excisional biopsy remains unknown. The purpose of this study was to evaluate the relationship between diagnostic excisional and core biopsies relative to surgical treatment procedures.
METHODS: We analyzed our data collected prospectively from 1995 through 2000, which included inpatient and outpatient surgical data, office visits, and radiology biopsy data including stereotactic, mammotome, and ultrasound core biopsies. The Cochran-Armitage trend test was used to assess the shift in diagnostic technique.
RESULTS: From 1995 through 2000 there were 2,631 core biopsies performed, 2,685 excisional biopsies, 2,881 surgical procedures for breast cancer, and 51,109 office visits. Although the percentage of core biopsies relative to excisional biopsies increased from 31% to 68% (P <0.001), the percentage of biopsies relative to the number of office visits remained stable at 10% to 11%. The percentage of breast cancer procedures relative to office visits also remained stable at 5% to 6%.
CONCLUSIONS: Our data indicate that core biopsies are being performed more often than excisional biopsies. Nevertheless, one in three biopsies done at our institution is excisional.

Entities:  

Mesh:

Year:  2002        PMID: 12383901     DOI: 10.1016/s0002-9610(02)00944-3

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  6 in total

1.  Can unenhanced breast MRI be used to decrease negative biopsy rates?

Authors:  Sibel Kul; Şükrü Oğuz; İlker Eyüboğlu; Özlem Kömürcüoğlu
Journal:  Diagn Interv Radiol       Date:  2015 Jul-Aug       Impact factor: 2.630

2.  The accuracy of ultrasound, stereotactic, and clinical core biopsies in the diagnosis of breast cancer, with an analysis of false-negative cases.

Authors:  Mary F Dillon; Arnold D K Hill; Cecily M Quinn; Ann O'Doherty; Enda W McDermott; Niall O'Higgins
Journal:  Ann Surg       Date:  2005-11       Impact factor: 12.969

3.  A decade of change: an institutional experience with breast surgery in 1995 and 2005.

Authors:  Amber A Guth; Beth Ann Shanker; Daniel F Roses; Deborah Axelrod; Baljit Singh; Hildegard Toth; Richard L Shapiro; Karen Hiotis; Thomas Diflo; Joan F Cangiarella
Journal:  Breast Cancer (Auckl)       Date:  2008-03-25

4.  Ultrasound-guided large-core needle biopsies of breast lesions: analysis of 962 cases to determine the number of samples for reliable tumour classification.

Authors:  G Sauer; H Deissler; K Strunz; G Helms; E Remmel; K Koretz; R Terinde; R Kreienberg
Journal:  Br J Cancer       Date:  2005-01-31       Impact factor: 7.640

5.  The Impact of Rurality and Disadvantage on the Diagnostic Interval for Breast Cancer in a Large Population-Based Study of 3202 Women in Queensland, Australia.

Authors:  Philippa H Youl; Joanne F Aitken; Gavin Turrell; Suzanne K Chambers; Jeffrey Dunn; Christopher Pyke; Peter D Baade
Journal:  Int J Environ Res Public Health       Date:  2016-11-19       Impact factor: 3.390

6.  Trends in breast biopsies for abnormalities detected at screening mammography: a population-based study in the Netherlands.

Authors:  V van Breest Smallenburg; J Nederend; A C Voogd; J W W Coebergh; M van Beek; F H Jansen; W J Louwman; L E M Duijm
Journal:  Br J Cancer       Date:  2013-05-21       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.